Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing \u00a318.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative \u2018Springboard Fellowship\u2019, which offers selected fellows an extra two years of funding to further advance their research and professional development.
Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled \u201cSmall contacts, big decisions \u2013 early signal processing by T cells\u201d. This has been awarded jointly with Professor Anna Lippert of the University of W\u00fcrzburg.
Congratulations to Dr Zakariye Ashkir who received the Best Scientific Abstract Award from the Association of Inherited Cardiac Conditions at their Annual Conference held in Cambridge earlier this month.
Researchers from RDM\u2019s Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and the MRC Weatherall Institute of Molecular Medicine (WIMM) took centre stage at this year's IF Oxford Science and Ideas Festival with some exciting and interactive public engagement activities.
Two interns who have recently graduated from the Research Experience for Peruvian Undergraduates (REPU) have described how their experience of working alongside RDM researchers has opened doors to new opportunities.
AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.
People diagnosed with type 2 diabetes before 40 years of age, have nearly four times the risk of death compared with the general UK population, a new study carried out at the University of Oxford\u2019s Radcliffe Department of Medicine has found.
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.
Robin Choudhury, Professor of Cardiovascular Medicine, has written a book about the art and science of the heart. Here he answers some questions about the origins and highlights of the project.
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
COPCOV, the world\u2019s largest COVID-19 chemoprevention study, published results today showing that hydroxychloroquine (HCQ) has a moderate benefit in preventing COVID-19. The COPCOV trial was led globally by the Mahidol Oxford Tropical Medicine Research Unit (MORU), Thailand. The Diabetes Trials Unit (DTU) was the UK coordinating centre for the trial, helped develop the protocol, and was responsible for managing UK sites, approvals and procedures.
Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, a new study by researchers at the Radcliffe Department of Medicine\u2019s Diabetes Trial Unit has found.
World-leading cardiology experts are to convene at the annual European Society of Cardiology (ESC) Congress in London from tomorrow (Friday 30 August).
![\"A](\"https://www.rdm.ox.ac.uk/news/study-to-evaluate-treatment-of-autonomous-cortisol-secretion/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n